Analysis of the R2 Genomics Analysis and Visualization Platform (http://r2.amc.nl) further verified that ADAMTS9-AS2 expression was negatively correlated with MYCN in patients with neuroblastoma (Pearson’s correlation coefficient –0.360, P < 0.0001, Supplemental Figure 5B). Here, ADAMTS9 is linked to neuroblastoma.